Clinical trial
Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation in Patients Undergoing General Anaesthesia - a Multicentre Randomised Controlled Trial -The ROCVIDEO Trial
NCT06564857 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Remifentanil Versus Rocuronium for Optimizing Video Laryngoscopy-assisted Tracheal Intubation in Patients Undergoing General Anaesthesia - a Multicentre Randomised Controlled Trial -The ROCVIDEO Trial
- Lead sponsor
- Nordsjaellands Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 17, 2025
- Completion date
- April 8, 2027
- Enrollment
- 2,684 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
remifentanil, rocuronium, tracheal intubation, video laryngoscopy